Jean‐Yves Douillard
0000-0002-6540-7333
Publication & Citation Trends
Most Cited Works
Publications
383 total
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS PDF
Cited by 584
OpenAlex
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer PDF
Cited by 3,395
OpenAlex
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial PDF
Cited by 942
OpenAlex
Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status PDF
Cited by 444
OpenAlex
Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer PDF
Cited by 2,233
OpenAlex
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making PDF
Cited by 1,520
OpenAlex
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Cited by 1,796
OpenAlex
Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial PDF
Cited by 492
OpenAlex
... d’Aventis
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(197)
Lung Cancer Treatments and Mutations
(155)
Cancer Treatment and Pharmacology
(87)
Gastric Cancer Management and Outcomes
(73)
Lung Cancer Research Studies
(60)
Frequent Co-Authors
Affiliations
AstraZeneca (United Kingdom)
United States Food and Drug Administration
Amgen (United States)
Memorial Sloan Kettering Cancer Center
Uppsala University Hospital